Altria to stop selling certain brands of e-cigarettes that appeal to young people


In a recent interview, FDA Commissioner Dr Scott Gottlieb said that while e-cigarettes may be a preferable alternative to combustible tobacco cigarettes, they are not without risk.

“Whenever you inhale vaping products, there is every reason to believe that there are risks associated with them,” he said.

Dr Gottlieb also noted that he is re-examining the use of menthol in certain products, which has been of particular concern in African American communities targeted by menthol cigarette makers like Newport and Kools in recent years. “It was a mistake for the agency to back down on menthol,” he said.

The FDA is also moving on other fronts that threaten the tobacco industry. In response to a court ruling, the agency said last month it would speed up the issuance of new graphic warnings on packages ordered years ago by Congress. It also offers to lower the nicotine levels in cigarettes, making them non-addictive.

Other concerns for Altria include FDA approval of IQOS, the pen-shaped electronic device developed by Philip Morris International, which the company claims heats tobacco sticks but does not burn them. Although Philip Morris has sought approval, Altria would distribute the device in the United States.

In January, a federal advisory committee recommended that the FDA reject an offer to sell the product as safer than traditional cigarettes. The agency has yet to make a final decision on whether the product can be sold as a reduced risk product, or not at all.

Altria has also recently increased its political donations. On September 19, the tobacco company made its biggest contribution of the year, $ 150,000 to the Congressional Leadership Fund, a so-called Super Pac aimed at electing Republicans to the House of Representatives, according to the Center for Responsive Politics. , which tracks spending policies. Last year, Altria gave the organization a total of $ 82,930.

Source link

Leave A Reply

Your email address will not be published.